SenzaGen (Sweden) Insiders
| SENZA Stock | SEK 6.95 0.10 1.42% |
SenzaGen employs about 29 people. The company is managed by 8 executives with a total tenure of roughly 27 years, averaging almost 3.0 years of service per executive, having 3.63 employees per reported executive. Breaking down SenzaGen's management performance can provide insight into the firm performance.
| Marisa Meloni Insider Founder Srl |
| Tina Lawesson Director IR and Communications Director |
SenzaGen |
SenzaGen Management Team Effectiveness
The company has return on total asset (ROA) of (0.1691) % which means that it has lost $0.1691 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3224) %, meaning that it generated substantial loss on money invested by shareholders. SenzaGen's management efficiency ratios could be used to measure how well SenzaGen manages its routine affairs as well as how well it operates its assets and liabilities.SenzaGen Workforce Comparison
SenzaGen AB is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 9,118. SenzaGen adds roughly 29.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (1.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.95) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.95. SenzaGen AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. SenzaGen AB Price Series Summation is a cross summation of SenzaGen price series and its benchmark/peer.
SenzaGen Notable Stakeholders
A SenzaGen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as SenzaGen often face trade-offs trying to please all of them. SenzaGen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting SenzaGen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marianne Olsson | Chief Financial Officer | Profile | |
| Tina Lawesson | IR and Communications Director | Profile | |
| Peter Nahlstedt | Director | Profile | |
| Marisa Meloni | Founder Srl | Profile | |
| Anna Hansson | Chief Commercial Officer | Profile | |
| Helen Olsson | VP HR | Profile | |
| Asa Nyhlen | VP Operations | Profile | |
| Henrik Johansson | Chief Scientist | Profile |
About SenzaGen Management Performance
The success or failure of an entity such as SenzaGen AB often depends on how effective the management is. SenzaGen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of SenzaGen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the SenzaGen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
SenzaGen AB, together with its subsidiary, markets, sells, and performs in vitro genomic allergen rapid detection sensitization tests for the screening of pharmaceutical candidates, and safety assessment of chemicals and cosmetic ingredients in Sweden and internationally. SenzaGen AB was incorporated in 2010 and is headquartered in Lund, Sweden. SenzaGen is traded on Stockholm Stock Exchange in Sweden.
Please note, the imprecision that can be found in SenzaGen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SenzaGen AB. Check SenzaGen's Beneish M Score to see the likelihood of SenzaGen's management manipulating its earnings.
SenzaGen Workforce Analysis
Traditionally, organizations such as SenzaGen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare SenzaGen within its industry.SenzaGen Manpower Efficiency
Return on SenzaGen Manpower
| Revenue Per Employee | 531.8K | |
| Revenue Per Executive | 1.9M | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 3.9M |
Additional Tools for SenzaGen Stock Analysis
When running SenzaGen's price analysis, check to measure SenzaGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenzaGen is operating at the current time. Most of SenzaGen's value examination focuses on studying past and present price action to predict the probability of SenzaGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenzaGen's price. Additionally, you may evaluate how the addition of SenzaGen to your portfolios can decrease your overall portfolio volatility.